Journal of Cardiovascular Pharmacology and Therapeutics

Papers
(The H4-Index of Journal of Cardiovascular Pharmacology and Therapeutics is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
A Comprehensive Review of PCSK9 Inhibitors43
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Di30
The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart27
Can We Decrease Epicardial and Pericardial Fat in Patients With Diabetes?22
Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database20
Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men20
Prediction of Drug-Induced Long QT Syndrome Using Machine Learning Applied to Harmonized Electronic Health Record Data19
Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways18
Fondaparinux Sodium: Recent Advances in the Management of Thrombosis16
COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges15
The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction14
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial13
Nitric Oxide–cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension13
0.015438079833984